BioLife Solutions, Inc. (BLFS)

24.86 -0.09 (-0.36%) USD  |  NASDAQ  |  Jan 09, 16:00
24.86 0.00 (0.00%) After-Hours: 20:00
More

BioLife Solutions Research and Development Expense (Annual): 7.912M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for BLFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
DexCom, Inc. 545.70M
INVO Fertility, Inc. 0.4897M
NeuroOne Medical Technologies Corp. 4.983M
SINTX Technologies, Inc. 5.201M
Nutriband, Inc. 3.119M